MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on February 17, 2005; DOI: 10.1124/mol.104.005082


0026-895X/05/6705-1556-1565$20.00
Mol Pharmacol 67:1556-1565, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.005082v1
67/5/1556    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Balzarini, J.
Right arrow Articles by Schols, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balzarini, J.
Right arrow Articles by Schols, D.
ORIGINAL ARTICLE

Marked Depletion of Glycosylation Sites in HIV-1 gp120 under Selection Pressure by the Mannose-Specific Plant Lectins of Hippeastrum Hybrid and Galanthus nivalis

Jan Balzarini, Kristel Van Laethem, Sigrid Hatse, Matheus Froeyen, Els Van Damme, Anders Bolmstedt, Willy Peumans, Erik De Clercq, and Dominique Schols

Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium (J.B., K.V.L., S.H., M.F., E.D.C., D.S.); University Hospitals Leuven, Leuven, Belgium (K.V.L.); Department of Clinical Virology, University of Göteborg, Göteborg, Sweden (A.B.); and Department of Molecular Biotechnology, Ghent University, Ghent, Belgium (E.V.D., W.P.)

Abstract

The plant lectins from Hippeastrum hybrid (HHA) and Galanthus nivalis (GNA) are 50,000-D tetramers showing specificity for {alpha}-(1,3) and/or {alpha}-(1,6)-mannose oligomers. They inhibit HIV-1 infection at a 50% effective concentration of 0.2 to 0.3 µg/ml. Escalating HHA or GNA concentrations (up to 500 µg/ml) led to the isolation of three HIV-1(IIIB) strains in CEM T cell cultures that were highly resistant to HHA and GNA, several other related mannose-specific plant lectins, and the monoclonal antibody 2G12, modestly resistant to the mannose-specific cyanovirin, which is derived from a blue-green alga, but fully susceptible to other HIV entry inhibitors as well as HIV reverse transcriptase inhibitors. These mutant virus strains were devoid of up to seven or eight of 22 glycosylation sites in the viral envelope glycoprotein gp120 because of mutations at the Asn or Thr/Ser sites of the N-glycosylation motifs. In one of the strains, a novel glycosylation site was created near a deleted glycosylation site. The affected glycosylation sites were predominantly clustered in regions of gp120 that are not involved in the direct interaction with either CD4, CCR5, CXCR4, or gp41. The mutant viruses containing the deleted glycosylation sites were markedly more infectious in CEM T-cell cultures than wild-type virus.


Received July 16, 2004; accepted February 17, 2005

Address correspondence to: Prof. J. Balzarini, Rega Institute for Medical Research, Minderbroedersstraat 10, B-3000 Leuven, Belgium. E-mail: jan.balzarini{at}rega.kuleuven.ac.be




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
J. G. Joyce, I. J. Krauss, H. C. Song, D. W. Opalka, K. M. Grimm, D. D. Nahas, M. T. Esser, R. Hrin, M. Feng, V. Y. Dudkin, et al.
An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions
PNAS, October 14, 2008; 105(41): 15684 - 15689.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
F. J. U. M. van der Meer, C. A. M. de Haan, N. M. P. Schuurman, B. J. Haijema, M. H. Verheije, B. J. Bosch, J. Balzarini, and H. F. Egberink
The carbohydrate-binding plant lectins and the non-peptidic antibiotic pradimicin A target the glycans of the coronavirus envelope glycoproteins
J. Antimicrob. Chemother., October 1, 2007; 60(4): 741 - 749.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
K. Hori, Y. Sato, K. Ito, Y. Fujiwara, Y. Iwamoto, H. Makino, and A. Kawakubo
Strict specificity for high-mannose type N-glycans and primary structure of a red alga Eucheuma serra lectin
Glycobiology, May 1, 2007; 17(5): 479 - 491.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. R. Teuton and C. R. Brandt
Sialic Acid on Herpes Simplex Virus Type 1 Envelope Glycoproteins Is Required for Efficient Infection of Cells
J. Virol., April 15, 2007; 81(8): 3731 - 3739.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. D. Pashov, J. Plaxco, S. V. Kaveri, B. Monzavi-Karbassi, D. Harn, and T. Kieber-Emmons
Multiple Antigenic Mimotopes of HIV Carbohydrate Antigens: Relating Structure and Antigenicity
J. Biol. Chem., October 6, 2006; 281(40): 29675 - 29683.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Balzarini, K. Van Laethem, W. J. Peumans, E. J. M. Van Damme, A. Bolmstedt, F. Gago, and D. Schols
Mutational Pathways, Resistance Profile, and Side Effects of Cyanovirin Relative to Human Immunodeficiency Virus Type 1 Strains with N-Glycan Deletions in Their gp120 Envelopes.
J. Virol., September 1, 2006; 80(17): 8411 - 8421.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
W.M. Blay, S. Gnanakaran, B. Foley, N. A. Doria-Rose, B. T. Korber, and N. L. Haigwood
Consistent Patterns of Change during the Divergence of Human Immunodeficiency Virus Type 1 Envelope from That of the Inoculated Virus in Simian/Human Immunodeficiency Virus-Infected Macaques
J. Virol., January 15, 2006; 80(2): 999 - 1014.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Balzarini, K. Van Laethem, S. Hatse, M. Froeyen, W. Peumans, E. Van Damme, and D. Schols
Carbohydrate-binding Agents Cause Deletions of Highly Conserved Glycosylation Sites in HIV GP120: A NEW THERAPEUTIC CONCEPT TO HIT THE ACHILLES HEEL OF HIV
J. Biol. Chem., December 9, 2005; 280(49): 41005 - 41014.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics